{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:25Z","timestamp":1786993705971,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Tokyo Cooperative Oncology Group"}],"content-domain":{"domain":["lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.lungcan.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T11:50:43Z","timestamp":1423482643000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0440-470X","authenticated-orcid":false,"given":"Tatsuro","family":"Fukuhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Maemondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-3317","authenticated-orcid":false,"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nukiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2015.02.004_bib0115","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-10-1087","article-title":"Tobacco and cancer: an American Association for Cancer Research policy statement","volume":"70","author":"Viswanath","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0125","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0130","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0140","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/annonc\/mds214","article-title":"Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin\u2013paclitaxel for chemo-naive non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)","volume":"24","author":"Inoue","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/JTO.0000000000000048","article-title":"Effectiveness of Gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q","volume":"9","author":"Watanabe","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/JTO.0b013e31828c3929","article-title":"Cytokeratin 19 fragment predicts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor in non-small-cell lung cancer harboring EGFR mutation","volume":"8","author":"Tanaka","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.lungcan.2014.01.022","article-title":"Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations","volume":"84","author":"Kim","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0165","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/annonc\/mdt127","article-title":"Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study","volume":"24","author":"Lee","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-11-0698","article-title":"Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors","volume":"11","author":"Filosto","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0175","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-12-1029","article-title":"Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells","volume":"12","author":"Filosto","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/JTO.0b013e31828b51d4","article-title":"Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by alpha1 nicotinic acetylcholine receptor-mediated activation in PC9 cells","volume":"8","author":"Wang","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0027-5107(02)00340-8","article-title":"Modulation of cigarette smoke-related end-points in mutagenesis and carcinogenesis","volume":"523-524","author":"De Flora","year":"2003","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2012.08.024","article-title":"Genomic landscape of non-small cell lung cancer in smokers and never-smokers","volume":"150","author":"Govindan","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0205","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.8004","article-title":"Overall survival in patients with advanced NSCLC harboring common (Del19\/L858R) EGFR mutations: analysis of two large, open-label phase III studies of afatinib vs chemotherapy, LUX-Lung 3 and LUX-Lung 6","volume":"32","author":"Yang","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0210","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1158\/1078-0432.CCR-06-0760","article-title":"Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels","volume":"12","author":"Helfrich","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0215","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1073\/pnas.0707270105","article-title":"Signaling networks assembled by oncogenic EGFR and c-Met","volume":"105","author":"Guo","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lungcan.2015.02.004_bib0220","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2012.02.063","article-title":"Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization","volume":"149","author":"Shan","year":"2012","journal-title":"Cell"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T15:55:17Z","timestamp":1566316517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0169500215000902"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.02.004","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}